NM_003482.4:c.11547_11557dupACACAGGCTGG
Variant summary
The NM_003482.4(KMT2D):c.11547_11557dupACACAGGCTGG (p.Val3853AspfsTer32) variant causes a frameshift change. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The gene KMT2D is a tumor suppressor gene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The gene KMT2D is a known oncogene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The gene KMT2D is a cancer driver gene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★).
Frequency
Consequence
NM_003482.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Illumina, PanelApp Australia
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, ClinGen
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Pathogenic. The variant received 11 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | TSG gene: ClinVar germline P/LP (single/no review) — Supporting (O1); O1 contributing sources (1.0 pts): ClinVar germline P/LP in TSG (★) | ||
| O2Null variant in tumour suppressor gene | Frameshift/stop-gained, NMD predicted, LoF oncogenic mechanism — O2 very strong (+8); Use caution in the presence of multiple transcripts; Gene confirmed as TSG in CancerMine (TSG: 29 citations, oncogene: 29 citations, driver: 10 citations).; Frameshift/stop-gained. NMD predicted: true. LoF mechanism: true. Downstream pathogenic count: 0. | ||
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_003482.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KMT2D | MANE Select | c.11547_11557dupACACAGGCTGG p.Val3853AspfsTer32 | frameshift | Exon 40 of 55 | Prot: NP_003473.3 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KMT2D | TSL:5MANE Select | c.11547_11557dupACACAGGCTGG p.Val3853AspfsTer32 | frameshift | Exon 40 of 55 | Prot: ENSP00000301067.7 UniProt: | |
KMT2D | c.11547_11557dupACACAGGCTGG p.Val3853AspfsTer32 | frameshift | Exon 40 of 56 | Prot: ENSP00000506726.1 UniProt: | ||
KMT2D | c.11556_11566dupACACAGGCTGG p.Val3856AspfsTer32 | frameshift | Exon 39 of 54 | Prot: ENSP00000509386.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD4 exome | Cov:47 | ||||
GnomAD4 genome | Cov:33 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Mutation Taster | N/A | 1/199 | disease causing (ClinVar) |
PhyloP100 | Benign | 0.12 |
Splicing Scores
No splicing scores have been computed for this variant.
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.